| Investor Type | Firm |
| Type of Fund | VC |
| Industries | BioTech |
| Stages | Seed, Early Stage, Series A, Pre-seed |
| Investing | Israel |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
Sapir Venture Partners is an venture capital firm that focuses on empowering entrepreneurs with groundbreaking ideas. They primarily target Israeli founders who are commercializing deep-tech and cutting-edge science, with a geographical focus on Boston, New York, and Israel. Their investment strategy spans from the earliest stages of a company's growth through to Seed and Seed+ rounds, providing a crucial platform for early-stage innovation and business development.
As a VC, Sapir Venture Partners provides not just capital investment but also strategic support to help startups navigate the challenges of establishing and scaling their businesses. With a minimum investment of $100,000 and a maximum of $5,000,000, they are positioned to make significant contributions to their portfolio companies. However, they find their 'sweet spot' at an investment level of $1,500,000, which often represents a balance between meaningful stake and risk management for the firm.
Their specialties include Seed, Early Stage, Series A, and Pre-seed investments, all critical phases where foundational business decisions are made and growth trajectories are established. This investment approach reflects the fund's commitment to fostering the development of innovative technologies and business models, as well as contributing to the broader startup ecosystem in their chosen regions of focus.
Headquarters are located in Jerusalem, Israel, anchoring the fund within a nation known for its high concentration of high-tech companies and entrepreneurial spirit.
We invest in Israeli founders commercializing deep-tech and cutting-edge science in Boston, New York, and Israel, at the earliest stages through to Seed+.
